Alembic Pharmaceuticals Limited Moxifloxacin Export Data — India (DGFT 2022–2026)

Name: Alembic Pharmaceuticals Limited Moxifloxacin Export Records India — #8 Exporter, 25 Shipments, $683.8K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Moxifloxacin

India Pharmaceutical Trade Intelligence

$32.8M336 Suppliers137 CountriesHS 30049099

ExportsIndia → NIGERIA44.8%India → UNITED STATES17.5%

ImportsUNITED STATES → India$160.3B BRAZIL → India$30.7B

#1 Buyer: NATIONAL TUBERCULOSIS

Alembic Pharmaceuticals Limited — Moxifloxacin Exporter #8 | $683.8K Trade Value | TransData Nexus | TransData Nexus

Alembic Pharmaceuticals Limited — Moxifloxacin Exporter Profile

Indian Pharmaceutical Exporter · #8 for Moxifloxacin · $683.8K export value · DGFT Verified

Alembic Pharmaceuticals Limited is the #8 Indian exporter of Moxifloxacin with $683.8K in export value and 25 verified shipments. Alembic Pharmaceuticals Limited holds a 2.1% market share in Moxifloxacin exports across 1 countries. The company exports 37 pharmaceutical products worth $127.6M across 16 therapeutic categories.

Alembic Pharmaceuticals Limited — Moxifloxacin Export Profile: Buyers & Destinations

Alembic Pharmaceuticals Limited Moxifloxacin export treemap — buyers and destination countries | TransData Nexus

Where Does India Export Moxifloxacin?

Country	Value	Shipments	Share
UNITED STATES	$5.8M	178	35.1%
NIGERIA	$2.8M	55	16.8%
NETHERLANDS	$1.7M	46	10.2%
THAILAND	$1.0M	38

Who Are the Top Buyers of Moxifloxacin from India?

Buyer	Country	Value	Orders
MYLAN INSTITUTIONAL INC 2898	UNITED STATES	$742.1K	16
AUROLOGISTICS LLC, (AUROBINDO PHARM	UNITED STATES	$650.0K	13
AUROBINDO PHARMA USA., INC,	UNITED STATES	$442.3K	9
TOPONE DISTRIBUTION LTD	CAMBODIA	$389.9K	14
I+SOLUTIONS	NETHERLANDS	$383.6K	9
J. KNIPPER & COMPANY	UNITED STATES	$381.1K	12
I+ SOLUTIONS,	NETHERLANDS	$350.0K	7
NORTHSTAR DISTRIBUTION CENTER 8912	UNITED STATES	$300.0K	6
MICRO NOVA PHARMACEUTICALS IND	NIGERIA	$300.0K	6
NATIONAL TUBERCULOSIS AND LEPROSY	NIGERIA	$100.0K	2

India's Moxifloxacin is purchased by 731 buyers worldwide. The top buyer is MYLAN INSTITUTIONAL INC 2898 (UNITED STATES), followed by AUROLOGISTICS LLC, (AUROBINDO PHARM and AUROBINDO PHARMA USA., INC,.

How Does Alembic Pharmaceuticals Limited Compare to Nearest Moxifloxacin Exporters?

Exporters ranked immediately above and below #8 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
6	MYLAN LABORATORIES LIMITED	$1.0M	28	4	$36.8K
7	AUROLAB TRUST	$806.3K	192	46	$4.2K
8	ALEMBIC PHARMACEUTICALS LIMITED ★	$683.8K	25	1	$27.4K
9	MACLEODS PHARMACEUTICALS LIMITED	$656.3K	20	10	$32.8K
10	MANKIND PHARMA LIMITED	$452.0K	11	2	$41.1K

Alembic Pharmaceuticals Limited ranks #8 among 336 Indian Moxifloxacin exporters. Average shipment value of $27.4K compared to the market average of $42.4K. The closest competitors by value are MYLAN LABORATORIES LIMITED and AUROLAB TRUST.

Which Indian Ports Ship Moxifloxacin Exports?

Port	Shipments	% Share
SAHAR AIR	311	12.9%
SAHAR AIR CARGO ACC (INBOM4)	263	10.9%
DELHI AIR CARGO ACC (INDEL4)	152	6.3%
DELHI AIR	132	5.5%
NHAVA SHEVA SEA (INNSA1)	126	5.2%
Bombay Air	119	4.9%
CHENNAI AIR	111	4.6%
CHENNAI AIR CARGO ACC (INMAA4)	93	3.9%

Geopolitical & Trade Policy Impact on Alembic Pharmaceuticals Limited's Moxifloxacin Exports

Alembic's export operations are intricately linked to global trade routes, making them susceptible to geopolitical tensions. The recent escalation of conflicts in the Middle East, particularly the Israel-Iran tensions, has led to heightened security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor. Major carriers have altered their routes, opting for the longer passage around the Cape of Good Hope, resulting in extended transit times by 10–20 days and increased freight rates by 40–50% on key India–Europe routes. (livemint.com) For Alembic, which exports to European markets, these disruptions could lead to delays and elevated shipping costs, impacting supply chain efficiency and profitability.

Conversely, the ongoing U.S.-China trade tensions have created opportunities for Indian pharmaceutical exporters. The United States' efforts to diversify its supply chain away from China have opened avenues for companies like Alembic to strengthen their presence in the U.S. market. The company's proactive approach is evident in its acquisition of Utility Therapeutics Ltd., facilitating entry into the U.S. branded drug segment. (pharma.economictimes.indiatimes.com) However, compliance with the European Union's Falsified Medicines Directive (FMD) remains a critical factor for Alembic's operations in Europe. Ensuring adherence to serialization and traceability requirements is essential to maintain market access and avoid regulatory penalties.

Alembic Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

Alembic Pharmaceuticals has consistently demonstrated adherence to stringent regulatory standards set by agencies such as the USFDA, WHO, and EU GMP. The company's manufacturing facilities have received approvals from various international regulatory bodies, underscoring its commitment to quality and compliance. (en.wikipedia.org) Notably, Alembic's proactive approach to addressing regulatory challenges is evident in its successful resolution of the nitrosamine issue affecting products like Duloxetine. By stabilizing the product and obtaining necessary dossier approvals, the company has reinforced its dedication to product safety and regulatory compliance. (alembiclimited.com)

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Moxifloxacin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Alembic Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 137+ countries, 731+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Moxifloxacin

Moxifloxacin

Alembic Pharmaceuticals Limited — Moxifloxacin Exporter Profile

Alembic Pharmaceuticals Limited — Moxifloxacin Export Profile: Buyers & Destinations

Where Does India Export Moxifloxacin?

Who Are the Top Buyers of Moxifloxacin from India?

What Is India's Total Moxifloxacin Export Value and How Much Does Alembic Pharmaceuticals Limited Contribute?

What Is the Average Shipment Value for Alembic Pharmaceuticals Limited's Moxifloxacin Exports?

How Does Alembic Pharmaceuticals Limited Compare to Other Indian Moxifloxacin Exporters?

Regulatory Requirements: Exporting Moxifloxacin to Key Markets

United States — FDA

Nigeria — NAFDAC

How Does Alembic Pharmaceuticals Limited Compare to Nearest Moxifloxacin Exporters?

Which Indian Ports Ship Moxifloxacin Exports?

What Other Advanced Antibiotics Products Does Alembic Pharmaceuticals Limited Export?

Geopolitical & Trade Policy Impact on Alembic Pharmaceuticals Limited's Moxifloxacin Exports

Alembic Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

About Alembic Pharmaceuticals Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Moxifloxacin Export Data from Alembic Pharmaceuticals Limited

Moxifloxacin Stats

Company Overview

Top Products by Alembic Pharmaceuticals Limited

Related Analysis

Need Detailed Export Data?

Data Source